Pediatric Drug Delivery Challenges and Solutions
Summary: Physiological changes happen from birth through adolescence—leading to differences in pharmacokinetics (PK) and pharmacodynamics (PD)—developing medicines for the pediatric population can be challenging, requiring different formulations, different dosage forms and strengths, or different routes of administration depending on the patient’s age. Read the latest article from Pharmaceutical Technology featuring Pascale Clement, PhD and Uwe Hanenberg, PhD at Catalent to learn more about new technologies for developing and delivering optimal dosage forms that address adherence and acceptability in pediatric populations.